Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ProQR Therapeutics (PRQR) Assets Average (2016 - 2023)

ProQR Therapeutics' Assets Average history spans 3 years, with the latest figure at $151.5 million for Q4 2023.

  • On a quarterly basis, Assets Average rose 1.83% to $151.5 million in Q4 2023 year-over-year; TTM through Dec 2023 was $151.5 million, a 1.83% increase, with the full-year FY2025 number at $155.4 million, down 5.22% from a year prior.
  • Assets Average hit $151.5 million in Q4 2023 for ProQR Therapeutics, down from $157.9 million in the prior quarter.
  • Over the last five years, Assets Average for PRQR hit a ceiling of $55.3 billion in Q2 2021 and a floor of $148.8 million in Q4 2022.
  • Historically, Assets Average has averaged $9.4 billion across 3 years, with a median of $187.2 million in 2022.
  • Biggest five-year swings in Assets Average: crashed 99.63% in 2022 and later rose 1.83% in 2023.
  • Tracing PRQR's Assets Average over 3 years: stood at $235.1 million in 2021, then plummeted by 36.71% to $148.8 million in 2022, then rose by 1.83% to $151.5 million in 2023.
  • Business Quant data shows Assets Average for PRQR at $151.5 million in Q4 2023, $157.9 million in Q3 2023, and $165.4 million in Q2 2023.